Randomized, double-blind, placebo-controlled study vs data in the daily practice using linaclotide in patients with irritable bowel syndrome with constipation

Neurogastroenterol Motil. 2018 May;30(5):e13363. doi: 10.1111/nmo.13363.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Constipation*
  • Double-Blind Method
  • Humans
  • Irritable Bowel Syndrome*
  • Japan
  • Peptides

Substances

  • Peptides
  • linaclotide